We are committed to ensuring the medicines we deliver are accessible and affordable for those who need them.
We are committed to ensuring the medicines we deliver are accessible and affordable for those who need them.
Our Pricing Principles & Perspectives
Prescription Medicine Pricing: Advancing Responsible Leadership
At Sanofi, we have a longstanding commitment to fostering healthcare systems that make our treatments accessible and affordable to those in need.
Our Pricing Principles detail how we price our medicines and advocate for policy solutions to make the system work better for patients and their care teams. By publishing results over the past decade, we aim to build transparency and enable a more informed U.S. dialogue on medicine pricing.
The Three Pillars of Our Pricing Principles
Clear Rationale for Pricing:
We take a holistic approach to pricing new medicines, considering patient perspectives, clinical value compared to existing treatments, economic impact on overall healthcare costs, social contributions to quality of life, and system-wide affordability.
Reporting of U.S. Pricing Actions:
We balance innovation and responsibility to help contain healthcare spending. We adhere to responsible pricing principles for list price adjustments and annually disclose any mandatory supplemental rebates triggered by those actions.
Continued Transparency in the U.S.:
We annually disclose our average aggregate U.S. list and net price changes to foster better-informed discussions about patient access and affordability.
2025 Pricing Principles Report
This report outlines our principles, 2024 pricing decisions, and perspectives on advancing solutions to improve patient outcomes and affordability in the U.S. healthcare system.
Living Out Our Commitments
The Disconnect Between List Prices and Patient Costs
Prioritizing Patient Affordability: Our Patient Support Programs
A Closer Look at 340B
Action Driving Insulin Affordability
Navigating the Complexities of Accessing Specialty Medicine
Health Policy Solutions Protecting Innovation
MAT-US-2017357-v10.0-10/2025